Research Articles | Page 15 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years Oct 2019 Blood Advances Aplastic Anemia
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Consensus Recommendations for Severe Aplastic Anemia Aug 2024 Blood Advances Aplastic Anemia
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Modified Delphi panel consensus recommendations for management of severe aplastic anemia Aug 2024 Blood Advances Aplastic Anemia
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes Oct 2019 Blood Advances Myelodysplastic Syndromes (MDS)
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Feb 2025 Blood Advances Aplastic Anemia
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)